LMNOX — Patient Opportunity Trust
Data updated: 2026-08-31
LMNOX — Patient Opportunity Trust. United States Multi-Cap / All-Cap Blend / Core Equity · $2.01B AUM. Holdings, fees, performance and SEC filings.
LMNOX Fund Overview
LMNOX — Patient Opportunity Trust is a US mutual fund managed by Advisor Managed Portfolios, categorised as United States Multi-Cap / All-Cap Blend / Core Equity. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US mutual fund
- Manager: Advisor Managed Portfolios
- Category: United States Multi-Cap / All-Cap Blend / Core Equity
- Assets under management: $2.01B
- 1-year return: 34.3%
- Ticker: LMNOX
- SEC CIK: 0001970751
- SEC series ID: S000082973
- Share class ID: C000246408
LMNOX Holdings
Top 10 holdings of Patient Opportunity Trust by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets |
|---|---|
| Royalty Pharma PLC | 6.98% |
| Citigroup Inc | 6.97% |
| Alphabet Inc | 6.67% |
| UnitedHealth Group Inc | 6.21% |
| Amazon.com Inc | 5.64% |
| NVIDIA Corp | 4.98% |
| CVS Health Corp | 4.51% |
| QXO Inc | 4.48% |
| Norwegian Cruise Line Holdings | 4.21% |
| Precigen Warrant Restricted | 4.19% |
LMNOX Portfolio Allocation
Asset-class allocation of Patient Opportunity Trust by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 105.4% |
| Derivatives | 4.8% |
LMNOX Performance
Total returns for LMNOX (as of 2026-09-01), from SEC filings.
| Period | Total return |
|---|---|
| YTD | 10.2% |
| 1 year | 34.3% |
| 3 years (annualised) | 26.0% |
LMNOX Risk Information
Risk metrics for LMNOX, derived from monthly returns in SEC filings.
- 1-year volatility (annualised): 16.3%
LMNOX Costs and Fees
LMNOX costs about $139 per $10,000 invested per year in fund expenses.
- Net expense ratio: 1.39%
- Gross expense ratio: 1.44%
- Portfolio turnover: 27%
- Brokerage commissions: 11.58 bps of average net assets (SEC N-CEN)
LMNOX Cashflows
Over the 12 months to 2026-06, Patient Opportunity Trust had net outflows of $101.00M, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2026-06 | −$9.80M |
| 2026-05 | −$6.83M |
| 2026-04 | −$6.84M |
| 2026-03 | −$6.74M |
| 2026-02 | −$7.41M |
| 2026-01 | −$4.06M |
LMNOX Debt Constituents
No individual debt constituents are reported in Patient Opportunity Trust's latest SEC N-PORT filing.
LMNOX Prospectus and SEC Filings
Official Patient Opportunity Trust filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
- Prospectus (485BPOS) — filed 2026-04-30
- Prospectus (485BPOS) — filed 2025-04-25
- Prospectus (485BPOS) — filed 2025-02-19
- Portfolio holdings (N-PORT) — filed 2026-08-31
- Portfolio holdings (N-PORT) — filed 2026-06-01
- Portfolio holdings (N-PORT) — filed 2026-03-02
- Annual census (N-CEN) — filed 2026-03-13
- Annual census (N-CEN) — filed 2025-03-13
Related Funds
Other United States Multi-Cap / All-Cap Blend / Core Equity funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.